Skip to main content
Clinical Trials/NCT00353093
NCT00353093CompletedNot Applicable

Limited Versus Extended Ultrasonography for the Diagnosis of Clinically Symptomatic Deep Vein Thrombosis of the Lower Extremities. A Randomized Study

University of Padova0 sites2,000 target enrollmentStarted: January 1, 2003Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
2,000
Primary Endpoint
To assess(1) the prevalence and location of venous thrombosis

Study Overview

Brief Summary

Currently, patients with suspected deep vein thrombosis (DVT) of the lower extremities receive the ultrasound investigation of their deep vein system, either by limited ultrasonography (ultrasonography confined to the proximal veins, repeating the test after one week in patients with positive D-dimer) or by extended ultrasonography (ultrasonography extented to the entire deep vein system of the legs). No study has directly compared the two strategies to assess their accuracy and safety. We plan to compare the accuracy and safety of the two strategies in a prospective randomized study addressing more than 2000 consecutive outpatients presenting with the clinical suspicion of DVT.

Detailed Description

All consecutive outpatients referred to the study center with clinically suspected deep vein thrombosis are potentially eligible for inclusion. Patients are excluded if they have a history of previous venous thromboembolism, have clinical suspicion of pulmonary embolism, have a life expectancy shorter than 3 months, have used therapeutic doses of unfractionated heparin, low molecular weight heparin or oral anticoagulants for more than 48 hours, have another indication for anticoagulant treatment, are pregnant, are aged less than 18 years, are inaccessible to follow-up, or refuse participation in the study.

Randomization Before randomization, patients are interviewed using a standardized questionnaire in order to collect information on risk factors for venous thrombosis, and the presence of several clinical signs and symptoms. Subsequently, they are randomized to the limited or the extended ultrasound strategy through computer generated lists, each of 100 patients arranged in balanced blocks of 10, specific for each center. The list is accessible only for a study nurse who informed the study physicians about group allocation once patients had provided informed consent.

Initial diagnostic workup Patients randomized to limited ultrasonography undergo compression ultrasonography, confining the investigation to the common femoral and the popliteal vein down to its trifurcation. In patients with normal findings D-dimer testing is performed, and they are subsequently managed according to its results: patients with normal D-dimer levels do not receive further investigation, while those with abnormal test are scheduled for repeat compression ultrasonography within one week.

Patients randomized to the extended ultrasonography receive first the evaluation of the proximal vein system, including the common femoral, the superficial femoral and the popliteal vein down its trifurcation. Then patients with compressible proximal veins undergo the extensive evaluation of the calf vein system, including the anterior tibial, posterior tibial and peroneal veins, and, if the deep veins were normal, also of the muscular (gastrocnemial and soleal) veins.

Limited ultrasonography and D-dimer The common femoral at the groin, and the popliteal vein down to its branching into the calf deep veins at the popliteal fossa, are examined in the transverse plane only, with a 7.5 MHz linear probe. The test results are categorized as normal (compressible veins) or abnormal (non compressible veins).

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Diagnostic
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • outpatients with clinically suspected deep vein thrombosis of the lower extremities

Exclusion Criteria

  • history of previous venous thromboembolism
  • clinical suspicion of pulmonary embolism
  • life expectancy shorter than 3 months
  • therapeutic doses of unfractionated heparin, low molecular weight heparin or oral anticoagulants for more than 48 hours
  • another indication for anticoagulant treatment
  • pregnancy
  • age less than 18 years
  • inaccessibility to follow-up
  • refused participation in the study

Outcomes

Primary Outcomes

To assess(1) the prevalence and location of venous thrombosis

as shown by the initial diagnostic workup; (2) the rate of

symptomatic venous thromboembolic events (including proximal

vein thrombosis, isolated thrombosis of the tibial or peroneal

veins in either leg, and pulmonary embolism) during three months

of follow up in patients with an initially normal diagnostic workup.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
University of Padova
Sponsor Class
Other

Similar Trials